Laboratory Study of Cancer & Immune Cells in Ascites Fluid of Ovarian Cancer Patients to Test Alternative Therapies

Phenotypic Characterization Tumor-infiltrating Lymphocytes at Diagnosis and After Chemotherapy in Ovarian Cancer

NCT03922776 ·Status: TERMINATED ·Phase: NA

Study of Safety & Biological Activity of IP IMNN-001 (also Known As GEN-1) with Neoadjuvant Chemo in Ovarian Cancer

NCT02480374 ·Status: COMPLETED ·Phase: PHASE1

Circulating Tumor DNA as an Early Marker of Recurrence and Treatment Efficacy in Ovarian Carcinoma

NCT03302884 ·Status: UNKNOWN ·Phase: NA

The Culture of Advanced or Recurrent Ovarian Cancer Organoids and Drug Screening

NCT05290961 ·Status: UNKNOWN

Vaccine Therapy in Treating Patients With Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

NCT00066729 ·Status: COMPLETED ·Phase: PHASE1

Open Label Immunotherapy Trial for Ovarian Cancer

NCT03556566 ·Status: UNKNOWN ·Phase: PHASE2

Study of Oncoimmunome for the Treatment of Stage III/IV Ovarian Carcinoma

NCT02933073 ·Status: TERMINATED ·Phase: PHASE1

Availability & Effect of Post-OP Ketorolac on Ovarian, Fallopian Tube or Primary Peritoneal Cancer

NCT01670799 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Risk of Ovarian Cancer in Patients With a Pelvic Mass

NCT00315692 ·Status: COMPLETED

A Clinical Trial of Autologous Oxidized Tumor Cell Lysate Vaccine For Recurrent Ovarian, Fallopian Tube or Primary Peritoneal Cancer

NCT01312389 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer

NCT04794322 ·Status: RECRUITING

Using Aspirin to Improve Immunological Features of Ovarian Tumors

NCT05080946 ·Status: RECRUITING ·Phase: EARLY_PHASE1

Laboratory Study in Predicting Tumor Response to Chemotherapy in Patients With Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

NCT00897039 ·Status: UNKNOWN

A Trial Using Novel Markers to Predict Malignancy in Elevated-Risk Women

NCT01121640 ·Status: COMPLETED ·Phase: NA

Infusion of Autologous T Cells Engineered to Target FSH Receptor in Recurrent Ovarian Cancer

NCT05316129 ·Status: RECRUITING ·Phase: PHASE1

Appraising Medical Trial Experiences of Ovarian Cancer Patients

NCT05801796 ·Status: NOT_YET_RECRUITING

Effect of Flutamide on Biomarkers in Blood and Tissue Samples From Patients at High Risk of Ovarian Cancer

NCT00699907 ·Status: COMPLETED ·Phase: PHASE2

Study of Tumor Tissue Samples From Patients Who Have Undergone Surgery for Advanced Stage III or Stage IV Ovarian Epithelial Cancer

NCT01000259 ·Status: RECRUITING

IMPACT: A Randomized WOO Study of Novel Therapeutic Agents in Women Triaged to Primary Surgery for EOC

NCT03378297 ·Status: COMPLETED ·Phase: EARLY_PHASE1

A Study of Long-Term Responders on Olaparib

NCT02489058 ·Status: COMPLETED

Cancer Stem Cell Assay Directed Chemotherapy in Recurrent Platinum Resistant Ovarian Cancer

NCT03949283 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Ovarian Tumor Biopsies to Study Response to Treatments

NCT02952521 ·Status: COMPLETED

YKL-40 in Serum Samples From Patients With Newly Diagnosed Stage III-IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer Receiving Chemotherapy

NCT00899093 ·Status: TERMINATED

Clinical Trial to Screen Participants Who Are at High Genetic Risk for Ovarian Cancer

NCT00039559 ·Status: UNKNOWN ·Phase: NA

Removal of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk

NCT00043472 ·Status: COMPLETED